N-(1'-Allypyrrolidinyl 2'-methyl) 2-methoxy 4,5-azimido benzamide and
申请人:Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
公开号:US04039672A1
公开(公告)日:1977-08-02
The azimido benzamide of this invention and its pharmaceutically acceptable salts have an unusually and unexpectedly high therapeutic index and low toxicity in the treatment of emesis in mammals. Pharmacological testing demonstrated the superior efficacy of the compound of this invention over known, similar compounds.